RXST Live signaler | Maksimer profitt med Getagraph.com

KJøP 117075 min ago

@ $51.45

Utstedt: 14 feb 2024 @ 17:15

Avkastning: 19.88%

Forrige signal: feb 14 - 15:33

Forrige signal: Selg

Avkastning: -0.56 %

Live Chart Being Loaded With Signals

Commentary (3 mai 2024 @ 22:00):

Stats
Dagens volum	532 855
Gjennomsnittsvolum	403 580
Markedsverdi	2.29B
EPS	$0 ( 2024-02-28 )
Neste inntjeningsdato	( $-0.170 ) 2024-05-06
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-43.74
ATR14	$0.111 (0.18%)

Insider Trading

Date	Person	Action	Amount	type
2024-05-01	Thunen Shelley B	Sell	10 000	Stock Option (right to buy)
2024-05-01	Thunen Shelley B	Buy	10 247	Common Stock
2024-05-01	Thunen Shelley B	Sell	9 620	Common Stock
2024-05-01	Thunen Shelley B	Sell	380	Common Stock
2024-04-01	Thunen Shelley B	Sell	8 857	Common Stock

INSIDER POWER
5.18
Last 100 transactions
Buy: 658 480 \| Sell: 615 832

Volum Korrelasjon

Lang: 0.34 (neutral)

Kort: 0.92 (very strong)

Signal:(66.216) Expect same movement, but be aware

RxSight, Inc. Korrelasjon

10 Mest positive korrelasjoner
CGEM	0.887
XM	0.886
SGEN	0.88
SRPT	0.878
INBKZ	0.877
NVCN	0.876
TIOAU	0.876
LIBY	0.874
VLAT	0.87
SILK	0.87

10 Mest negative korrelasjoner
LHDX	-0.902
TENX	-0.902
WINT	-0.895
ARTNA	-0.893
FFIE	-0.887
VRAY	-0.879
VRM	-0.878
MRCY	-0.877
REVB	-0.876
EBIX	-0.874

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

RxSight, Inc. Korrelasjon - Valuta/Råvare

0.70
( moderate )

0.78
( moderate )

0.67
( moderate )

0.56
( weak )

-0.81
( strong negative )

RxSight, Inc. Økonomi

Annual	2023
Omsetning:	$89.08M
Bruttogevinst:	$53.77M (60.36 %)
EPS:	$-1.410

FY	2023
Omsetning:	$89.08M
Bruttogevinst:	$53.77M (60.36 %)
EPS:	$-1.410

FY	2022
Omsetning:	$49.01M
Bruttogevinst:	$21.33M (43.52 %)
EPS:	$-2.41

FY	2021
Omsetning:	$22.59M
Bruttogevinst:	$4.52M (19.99 %)
EPS:	$-2.59

Financial Reports:

No articles found.

RxSight, Inc.

RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company's RxSight system includes RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery. It primarily serves cataract doctors. The company was formerly known as Calhoun Vision, Inc. and changed its name to RxSight, Inc. in February 2017. RxSight, Inc. was incorporated in 1997 and is headquartered in Aliso Viejo, California.

Sanntidsoppdatering for RxSight, Inc. [RXST]

Upcoming Earnings Alert